Report Detail

Request for Sample of this report

Medical Devices & Consumables Global AI Lung Screening System Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4658305
    • |
  • 16 February, 2026
    • |
  • Global
    • |
  • 100 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global AI Lung Screening System market size was valued at US$ 346 million in 2025 and is forecast to a readjusted size of US$ 763 million by 2032 with a CAGR of 11.9% during review period.
AI Lung Screening System is an integrated software-driven solution that supports early detection and risk stratification of lung cancer—primarily by analyzing low-dose CT (LDCT) scans in screening or incidental nodule workflows. The system typically performs automated lung nodule detection, segmentation, volumetry, growth tracking, malignancy risk scoring, and structured reporting, aiming to reduce radiologist workload, improve consistency, and standardize follow-up recommendations. In practice, it functions as a clinical decision support layer within radiology operations: it flags suspicious findings, prioritizes worklists, and helps quantify change over time. Commercially, “system” usually refers to a deployable product package (software + workflow integration + validation/regulatory package), rather than an algorithm alone, and is increasingly delivered as a platform with continuous model updates, audit trails, and performance monitoring.
From a multi-angle segmentation standpoint, the market can be parameterized by: (1) Clinical scenario: population LDCT screening vs incidental pulmonary nodules; (2) Algorithmic functions: detection-only, detection+volumetry, full risk scoring (e.g., malignancy probability), and longitudinal tracking; (3) Deployment: on-premise server, private cloud, public cloud/SaaS, or hybrid; (4) Integration depth: standalone viewer vs PACS/RIS embedded workflow with structured reporting; (5) Regulatory class & claims: CAD support vs triage vs quantified decision support. Additional quantitative “type” parameters include supported CT slice thickness, acceptable dose range, nodule size range (e.g., ≥3 mm), sensitivity at fixed false-positive rates, throughput (studies/hour), and interoperability standards (DICOM, HL7/FHIR).
In transaction terms, pricing commonly follows (a) annual subscription per site, (b) per-scan fee, or (c) enterprise license tied to volume tiers, with separate charges for integration, validation support, and service-level agreements. Procurement often runs through hospital IT/security reviews and radiology leadership, with pilots (3–6 months) preceding multi-year contracts. Key trends include tighter workflow embedding (worklist triage + structured reporting), expansion from single-task CAD to end-to-end nodule management, growing emphasis on generalizability and bias control across scanners and populations, and integration of multimodal data (clinical risk factors, prior imaging) to improve risk stratification. As screening volumes rise and radiologist shortages persist, vendors that can prove reduced recall burden, stable false-positive control, and seamless integration are best positioned for durable share gains.
This report is a detailed and comprehensive analysis for global AI Lung Screening System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Lung Screening System market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Lung Screening System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Lung Screening System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Lung Screening System market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Lung Screening System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Lung Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lunit, Aidoc, VUNO, Inc., Riverain Technologies, LLC, Viz.ai, RapidAI, Enlitic, ANNALISE-AI PTY LTD, INFERVISION TECHNOLOGY, Lianying Intelligent Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Lung Screening System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lung Cancer Early Screening
Pulmonary Nodule Detection & Tracking
High-Risk Population Screening
Incidental Lung Finding Screening
Others
Market segment by Imaging Modality & Data Source
LDCT-based Screening System
Standard Chest CT AI System
Others
Market segment by Deployment & Integration Model
On-premise
Private Cloud (Hospital-owned Cloud)
Public Cloud / SaaS
Others
Market segment by Application
Medical Institutions
Great Health Scene
Market segment by players, this report covers
Lunit
Aidoc
VUNO, Inc.
Riverain Technologies, LLC
Viz.ai
RapidAI
Enlitic
ANNALISE-AI PTY LTD
INFERVISION TECHNOLOGY
Lianying Intelligent Medical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Lung Screening System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Lung Screening System, with revenue, gross margin, and global market share of AI Lung Screening System from 2021 to 2026.
Chapter 3, the AI Lung Screening System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Lung Screening System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Lung Screening System.
Chapter 13, to describe AI Lung Screening System research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Lung Screening System by Type
    • 1.3.1 Overview: Global AI Lung Screening System Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Lung Screening System Consumption Value Market Share by Type in 2025
    • 1.3.3 Lung Cancer Early Screening
    • 1.3.4 Pulmonary Nodule Detection & Tracking
    • 1.3.5 High-Risk Population Screening
    • 1.3.6 Incidental Lung Finding Screening
    • 1.3.7 Others
  • 1.4 Classification of AI Lung Screening System by Imaging Modality & Data Source
    • 1.4.1 Overview: Global AI Lung Screening System Market Size by Imaging Modality & Data Source: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global AI Lung Screening System Consumption Value Market Share by Imaging Modality & Data Source in 2025
    • 1.4.3 LDCT-based Screening System
    • 1.4.4 Standard Chest CT AI System
    • 1.4.5 Others
  • 1.5 Classification of AI Lung Screening System by Deployment & Integration Model
    • 1.5.1 Overview: Global AI Lung Screening System Market Size by Deployment & Integration Model: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global AI Lung Screening System Consumption Value Market Share by Deployment & Integration Model in 2025
    • 1.5.3 On-premise
    • 1.5.4 Private Cloud (Hospital-owned Cloud)
    • 1.5.5 Public Cloud / SaaS
    • 1.5.6 Others
  • 1.6 Global AI Lung Screening System Market by Application
    • 1.6.1 Overview: Global AI Lung Screening System Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Medical Institutions
    • 1.6.3 Great Health Scene
  • 1.7 Global AI Lung Screening System Market Size & Forecast
  • 1.8 Global AI Lung Screening System Market Size and Forecast by Region
    • 1.8.1 Global AI Lung Screening System Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global AI Lung Screening System Market Size by Region, (2021-2032)
    • 1.8.3 North America AI Lung Screening System Market Size and Prospect (2021-2032)
    • 1.8.4 Europe AI Lung Screening System Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific AI Lung Screening System Market Size and Prospect (2021-2032)
    • 1.8.6 South America AI Lung Screening System Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa AI Lung Screening System Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Lunit
    • 2.1.1 Lunit Details
    • 2.1.2 Lunit Major Business
    • 2.1.3 Lunit AI Lung Screening System Product and Solutions
    • 2.1.4 Lunit AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Lunit Recent Developments and Future Plans
  • 2.2 Aidoc
    • 2.2.1 Aidoc Details
    • 2.2.2 Aidoc Major Business
    • 2.2.3 Aidoc AI Lung Screening System Product and Solutions
    • 2.2.4 Aidoc AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Aidoc Recent Developments and Future Plans
  • 2.3 VUNO, Inc.
    • 2.3.1 VUNO, Inc. Details
    • 2.3.2 VUNO, Inc. Major Business
    • 2.3.3 VUNO, Inc. AI Lung Screening System Product and Solutions
    • 2.3.4 VUNO, Inc. AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 VUNO, Inc. Recent Developments and Future Plans
  • 2.4 Riverain Technologies, LLC
    • 2.4.1 Riverain Technologies, LLC Details
    • 2.4.2 Riverain Technologies, LLC Major Business
    • 2.4.3 Riverain Technologies, LLC AI Lung Screening System Product and Solutions
    • 2.4.4 Riverain Technologies, LLC AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Riverain Technologies, LLC Recent Developments and Future Plans
  • 2.5 Viz.ai
    • 2.5.1 Viz.ai Details
    • 2.5.2 Viz.ai Major Business
    • 2.5.3 Viz.ai AI Lung Screening System Product and Solutions
    • 2.5.4 Viz.ai AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Viz.ai Recent Developments and Future Plans
  • 2.6 RapidAI
    • 2.6.1 RapidAI Details
    • 2.6.2 RapidAI Major Business
    • 2.6.3 RapidAI AI Lung Screening System Product and Solutions
    • 2.6.4 RapidAI AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 RapidAI Recent Developments and Future Plans
  • 2.7 Enlitic
    • 2.7.1 Enlitic Details
    • 2.7.2 Enlitic Major Business
    • 2.7.3 Enlitic AI Lung Screening System Product and Solutions
    • 2.7.4 Enlitic AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Enlitic Recent Developments and Future Plans
  • 2.8 ANNALISE-AI PTY LTD
    • 2.8.1 ANNALISE-AI PTY LTD Details
    • 2.8.2 ANNALISE-AI PTY LTD Major Business
    • 2.8.3 ANNALISE-AI PTY LTD AI Lung Screening System Product and Solutions
    • 2.8.4 ANNALISE-AI PTY LTD AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ANNALISE-AI PTY LTD Recent Developments and Future Plans
  • 2.9 INFERVISION TECHNOLOGY
    • 2.9.1 INFERVISION TECHNOLOGY Details
    • 2.9.2 INFERVISION TECHNOLOGY Major Business
    • 2.9.3 INFERVISION TECHNOLOGY AI Lung Screening System Product and Solutions
    • 2.9.4 INFERVISION TECHNOLOGY AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 INFERVISION TECHNOLOGY Recent Developments and Future Plans
  • 2.10 Lianying Intelligent Medical Technology
    • 2.10.1 Lianying Intelligent Medical Technology Details
    • 2.10.2 Lianying Intelligent Medical Technology Major Business
    • 2.10.3 Lianying Intelligent Medical Technology AI Lung Screening System Product and Solutions
    • 2.10.4 Lianying Intelligent Medical Technology AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lianying Intelligent Medical Technology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Lung Screening System Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Lung Screening System by Company Revenue
    • 3.2.2 Top 3 AI Lung Screening System Players Market Share in 2025
    • 3.2.3 Top 6 AI Lung Screening System Players Market Share in 2025
  • 3.3 AI Lung Screening System Market: Overall Company Footprint Analysis
    • 3.3.1 AI Lung Screening System Market: Region Footprint
    • 3.3.2 AI Lung Screening System Market: Company Product Type Footprint
    • 3.3.3 AI Lung Screening System Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Lung Screening System Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Lung Screening System Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Lung Screening System Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Lung Screening System Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Lung Screening System Consumption Value by Type (2021-2032)
  • 6.2 North America AI Lung Screening System Market Size by Application (2021-2032)
  • 6.3 North America AI Lung Screening System Market Size by Country
    • 6.3.1 North America AI Lung Screening System Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Lung Screening System Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Lung Screening System Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Lung Screening System Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Lung Screening System Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Lung Screening System Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Lung Screening System Market Size by Country
    • 7.3.1 Europe AI Lung Screening System Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Lung Screening System Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Lung Screening System Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Lung Screening System Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Lung Screening System Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Lung Screening System Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Lung Screening System Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Lung Screening System Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Lung Screening System Market Size by Region
    • 8.3.1 Asia-Pacific AI Lung Screening System Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Lung Screening System Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Lung Screening System Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Lung Screening System Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Lung Screening System Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Lung Screening System Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Lung Screening System Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Lung Screening System Consumption Value by Type (2021-2032)
  • 9.2 South America AI Lung Screening System Consumption Value by Application (2021-2032)
  • 9.3 South America AI Lung Screening System Market Size by Country
    • 9.3.1 South America AI Lung Screening System Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Lung Screening System Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Lung Screening System Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Lung Screening System Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Lung Screening System Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Lung Screening System Market Size by Country
    • 10.3.1 Middle East & Africa AI Lung Screening System Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Lung Screening System Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Lung Screening System Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Lung Screening System Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Lung Screening System Market Drivers
  • 11.2 AI Lung Screening System Market Restraints
  • 11.3 AI Lung Screening System Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Lung Screening System Industry Chain
  • 12.2 AI Lung Screening System Upstream Analysis
  • 12.3 AI Lung Screening System Midstream Analysis
  • 12.4 AI Lung Screening System Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI Lung Screening System. Industry analysis & Market Report on AI Lung Screening System is a syndicated market report, published as Global AI Lung Screening System Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Lung Screening System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo